GSK and Pfizer resolve RSV vaccine patent fightnews2025-04-04T19:36:29+00:00April 4th, 2025|Endpoints News|
Novavax’s approval delay may signal warning for vaccine makersnews2025-04-04T18:49:03+00:00April 4th, 2025|Endpoints News|
China’s retaliatory tariffs on US could mean more headwinds for drugmakersnews2025-04-04T17:25:01+00:00April 4th, 2025|Endpoints News|
States sue NIH over alleged grant cancellations, delaysnews2025-04-04T16:56:15+00:00April 4th, 2025|Endpoints News|
DOJ attorney says Boehringer Ingelheim has ‘tremendous leverage’ in IRA negotiationsnews2025-04-03T20:09:24+00:00April 3rd, 2025|Endpoints News|
FDA approves Amgen’s Uplizna in IgG4-related diseasenews2025-04-03T19:48:52+00:00April 3rd, 2025|Endpoints News|
FDA will consolidate to five ‘shared services offices’: HHS memonews2025-04-03T17:41:29+00:00April 3rd, 2025|Endpoints News|
Aldeyra gets second CRL for dry eye disease drugnews2025-04-03T14:52:46+00:00April 3rd, 2025|Endpoints News|
